Current answer
Does L-ergothioneine improve sleep?
Controlled human studies have reported sleep-related measures, but this preliminary profile does not determine that L-ergothioneine reliably improves sleep. Outcome priority, effect size, clinical importance, study independence, and replication still require full extraction and adversarial review.
Before a full review
Profile status
Source collection and claim mapping have begun. Full extraction, cross-examination, adjudication, and human approval are incomplete.
- Direction
- Not assigned
- Evidence stage
- Not assigned
- Certainty
- Not assigned
- Human review
- Not yet started
- Search indexing
- Noindex during development
- Next gate
- Primary-source extraction
Claims being mapped
These are common versions of the topic, not findings that the site endorses. Each requires its own outcome, population, and evidence test.
- Supports restful or better-quality sleep
- Helps people fall asleep faster
- Reduces nighttime waking
- Improves next-day alertness or recovery
- Supports sleep through antioxidant or stress-response pathways
Why this benefit has been proposed
The profile records the legitimate research rationale without treating that rationale as proof.
01
Sleep measures have appeared in controlled supplementation research.
02
Biological stress-response mechanisms are sometimes offered as a rationale, but a mechanism cannot establish a sleep benefit.
03
Subjective questionnaires and objective sleep measurements answer different questions and must not be treated as interchangeable.
Evidence landscape
Evidence categories are kept separate so mechanistic or animal findings do not make the human evidence appear stronger.
Two controlled human records with sleep-related outcomes are currently in the site database. Their prespecified endpoints, direct comparisons, multiplicity, and independence require full review.
No additional qualifying human intervention has yet been promoted into this profile.
No verified observational record has yet been selected for the sleep docket.
Preclinical sleep evidence has not yet been systematically collected for this review.
Mechanistic explanations remain hypotheses unless they connect to validated human sleep outcomes.
Verified records currently connected
These records have structured pages in the site database. Inclusion here identifies relevance; it is not a positive rating.
Human randomized controlled trial
Cognition, memory, and sleep randomized trial
Why it is relevant: Included sleep-related outcomes alongside cognitive measures.
Important boundary: Sleep was not the sole research question; outcome hierarchy and multiple analyses require careful interpretation.
Inspect the study record →Human randomized controlled research
Dose estimation and sleep-quality validation study
Why it is relevant: Directly examined dosing and subjective sleep-quality measures.
Important boundary: The full analysis, endpoint selection, clinical importance, and independent replication have not completed adversarial review.
Inspect the study record →Questions the full review must resolve
- Which sleep outcomes were prespecified as primary?
- Were benefits demonstrated directly against placebo rather than only within a treatment group?
- Were effects clinically noticeable and supported by objective measures?
- Has a comparable result been independently replicated?
Current language boundary
- “L-ergothioneine is being investigated in relation to sleep.”
- “Evidence mapping and human review are incomplete.”
- “May support sleep” only as a research hypothesis, paired with the incomplete-review status.
- Descriptions of individual studies must identify their design and principal limitations.
- Treats insomnia
- Clinically proven sleep aid
- Replaces sleep evaluation or established treatment
How this becomes a completed review
- 1Preliminary Evidence Profile
Claims, evidence categories, known records, and unresolved questions are mapped.
- 2Draft Evidence Review
Primary sources are extracted and the supporting case, cross-examination, rebuttal, and working adjudication are completed.
- 3Human Review in Progress
A human reviewer checks factual accuracy, interpretation, language, and unresolved risks.
- 4Review Complete
Approval is recorded before direction, evidence stage, certainty, and final language rulings are published.
Transparency record
- Page type
- Preliminary Evidence Profile
- Created
- September 20, 2026
- Evidence status
- Mapping in progress; no verdict assigned
- Human oversight
- Human review not yet started; no review conclusion has been approved
- Search status
- Excluded from search-engine indexing and the XML sitemap during development
- Methodology
- Adversarial Evidence Review Pilot
- AI assistance
- Codex assisted with claim mapping, page structure, and drafting. AI output was not treated as a scientific source.
- Ownership and conflicts
- Published by L-Ergothioneine.com. No active affiliate product links appear on this page.
Educational information only. This preliminary profile does not diagnose, prevent, or treat disease and does not provide personalized supplement advice. Do not start, stop, or change medical care based on this page.
Read the full disclaimer →